Management based on exhaled nitric oxide levels adjusted for atopy reduces asthma exacerbations in children: A dual centre randomized controlled trial

Pediatric Pulmonology

Volumn 50, Issue 6, 2015, Pages 535-543

  Petsky, Helen L ^a   Li, Albert M ^b   Au, Chun T ^b   Kynaston, Jennifer A ^c   Turner, Catherine ^d   Chang, Anne B ^a,e  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Asthma; Atopy; FeNO; Pediatrics

Indexed keywords

BUDESONIDE; CORTICOSTEROID DERIVATIVE; FLUTICASONE; FORMOTEROL; NITRIC OXIDE; SALMETEROL; BRONCHODILATING AGENT;

ARTICLE; ASTHMA; ATOPY; CHILD; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; ADOLESCENT; BREATH ANALYSIS; CLINICAL TRIAL; EXHALATION; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ASTHMA; BREATH TESTS; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; CHILD, PRESCHOOL; EXHALATION; FEMALE; FLUTICASONE; HUMANS; MALE; NITRIC OXIDE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84929270129     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23064     Document Type: Article

References (41)

1. Anderson HR, Gupta R, Strachan DP, Limb ES,. 50 years of asthma: UK trends from 1955 to 2004. Thorax 2007; 62: 85-90.
2. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ,. Status of childhood asthma in the United States, 1980 to 2007. Pediatrics 2009; 123: S131-S145.
3. Gupta R, Anderson HR, Strachan DP, Maier W, Watson L,. International trends in admissions and drug sales for asthma. Int J Tuberc Lung Dis 2006; 10: 138-145.
4. Asthma management handbook. Melbourne, Australia: National Asthma Council; 2006. Cited November 2009; Available from http://www.nationalasthma.org.au/handbook
5. Global Initiative for Asthma 2008. Cited November 2009. Available from http://www.ginasthma.org/guidelines-gina-report-global-strategy-for-asthma.html
6. British Guideline on the Management of Asthma, A national clinical guideline. Cited 2008; Available from http://www.brit-thoracic.org.uk/guidelines/asthma-guidelines.aspx
7. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, Khan M, Bush A,. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005; 171: 1077-1082.
8. Menzies D, Nair A, Lipworth BJ,. Non-invasive measurement of airway inflammation in asthma. J Asthma 2006; 43: 407-415.
9. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID,. Asthma exacerbations and sputum eosinophil counts: A randomised controlled trial. Lancet 2002; 360: 1715-1721.
10. Szefler S,. Facing the challenges of childhood asthma: What changes are necessary ? J Allergy Clin Immunol 2005; 115: 685-688.
11. Petsky HL, Cates CJ, Li AM, Kynaston JA, Turner C, Chang AB,. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2009; CD006340.
12. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR,. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352: 2163-2173.
13. Fritsch M, Uxa S, Horak F, Jr., Putschoegl B, Dehlink E, Szepfalusi Z, Frischer T,. Exhaled nitric oxide in the management of childhood asthma: A prospective 6-months study. Pediatr Pulmonol 2006; 41: 855-862.
14. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu AH, Wildfire JJ, Curry MD, Busse WW,. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: A randomised controlled trial. Lancet 2008; 372: 1065-1072.
15. de Jongste JC, Carraro S, Hop WC, Baraldi E,. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med 2009; 179: 93-97.
16. Shaw D, Perry MA, Thomas M, Green RH, Brightling C, Wardlaw AJ, Pavord ID,. The use of exhaled nitric oxide to guide asthma management. Am J Respir Crit Care Med 2007; 176: 231-237.
17. Pijnenburg M, Bakker E, Hop W, deJongste J,. Titrating steriods on exhaled nitric oxide in children with asthma: A randomised controlled trial. Am J Respir Crit Care Med 2005; 172: 831-836.
18. Powell H, Murphy VE, Taylor DR, Hensley MJ, McCaffery K, Giles W, Clifton VL, Gibson PG,. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: A double-blind, randomised controlled trial. Lancet 2011; 378: 983-990.
19. Stick S, Franklin P,. NO more dogma. Nitric oxide marker in asthma. Am J Respir Crit Care Med 2009; 179: 87-88.
20. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin A-C, Plummer AL, Taylor DR,. American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels for Clinical Applications. An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011; 184: 602-615.
21. Franklin PJ, Turner SW, Le Souef PN, Stick SM,. Exhaled nitric oxide and asthma: Complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax 2003; 58: 1048-1052.
22. Linhares D, Jacinto T, Pereira AM, Fonseca J,. Effects of atopy and rhinitis on exhaled nitric oxide values-A systematic review. Clin Transl Allergy 2011; 1: 8. DOI: 10.1186/2045-7022-1181-1188
23. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M,. Measuring quality of life in children with asthma. Qual Life Res 1996; 5: 35-46.
24. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M,. Measuring quality of life in the parents of children with asthma. Qual Life Res 1996; 5: 27-34.
25. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J,. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997; 10: 646-651.
26. Franklin PJ, Taplin R, Stick SM,. A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med 1999; 159: 69-73.
27. Silkoff PE, Erzurum SC, Lundberg JO, George SC, Marczin N, Hunt JF, Effros R, Horvath I,. ATS workshop proceedings: Exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc Am Thorac Soc 2006; 3: 131-145.
28. Ip MS, Karlberg EM, Chan KN, Karlberg JP, Luk KD, Leong JC,. Lung function reference values in Chinese children and adolescents in Hong Kong. II. Prediction equations for plethysmographic lung volumes. Am J Respir Crit Care Med 2000; 162: 430-435.
29. Eigen H, Bieler H, Grant D, Christoph K, Terrill D, Heilman DK, Ambrosius WT, Tepper RS,. Spirometric pulmonary function in healthy preschool children. Am J Respir Crit Care Med 2001; 163: 619-623.
30. Hibbert ME, Lannigan A, Landau LI, Phelan PD,. Lung function values from a longitudinal study of healthy children and adolescents. Pediatr Pulmonol 1989; 7: 101-109.
31. Santanello N, Davies G, Galant S, Pedinoff A, Sveum R, Seltzer J, Seidenberg B, Knorr B,. Validation of an asthma symptom diary for interventional studies. Arch Dis Childhood 1998; 80: 414-420.
32. Chang AB, Clark R, Sloots TP, Stone DG, Petsky HL, Thearle D, Champion AA, Wheeler C, Acworth JP,. A 5- versus 3-day course of oral corticosteroids for children with asthma exacerbations who are not hospitalised: A randomised controlled trial. Med J Aust 2008; 189: 306-310.
33. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, DeJongste J, Kerstjens H, Lazarus SC, Levy ML, O'Byrne P, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler S, Thomas M, Wenzel SE,. An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations. Standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180: 59-99.
34. Olin A-C, Bake B, Toren K,. Fraction of exhaled nitric oxide at 50 mL/s: Reference values for adult lifelong never-smokers. Chest 2007; 131: 1852-1856.
35. Malmberg LP, Petäys T, Haahtela T, Laatikainen T, Jousilahti P, Vartiainen E, Mäkelä MJ,. Exhaled nitric oxide in healthy nonatopic school-age children: Determinants and height-adjusted reference values. Pediatr Pulmonol 2006; 41: 635-642.
36. Gibson PG,. Using fractional exhaled nitric oxide to guide asthma therapy: Design and methodlogical issues for ASthma ALgorithm studies. Clin Exp Allergy 2009; 39: 478-490.
37. Jacinto T, Alving K, Correia R, Costa-Pereira A, Fonseca J,. Setting reference values for exhaled nitric oxide: A systematic review. Clin Respir J 2012; 12.
38. Smith AD, Cowan JO, Taylor DR,. Exhaled nitric oxide levels in asthma: Personal best versus reference values. J Allergy Clin Immunol 2009; 124: 714-718, e714.
39. Scott I,. Non-inferiority trials: Determining whether alternative treatments are good enough. Med J Aust 2009; 190: 326-330.
40. Wu AC, Tantisira K, Li L, Schuemann B, Weiss ST, Fuhlbrigge AL,. Childhood Asthma Management Program Research Group. Predictors of symptoms are different from predictors of severe exacerbations from asthma in children. Chest 2011; 140: 100-107.
41. Gibson PG, Powell H, Ducharme FM,. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations. J Allergy Clin Immunol 2007; 119: 344-350.